Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen in mild COVID-19 with immune regulation assessment
ChiCTR2100045647Phase 4Recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Apr 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial of Lianhua Qingwen in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shenzhen Third People's Hospital. Primary endpoint: Symptom disappearance rate. Started Apr 2021; status: recruiting.
02
Drugs
Lianhua Qingwen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2100045647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045647.